Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry
2005; 62: 593–602.
Ruscio, AM, Brown, TA, Chiu, WT, Sareen, J, Stein, MB, Kessler, RC. Social fears and social phobia in the United States: results from the National Comorbidity Survey Replication. Psychol Med
2008; 38: 15–28.
Wang, PS, Berglund, P, Olfson, M, Pincus, HA, Wells, KB, Kessler, RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry
2005; 62: 603–13.
den Boer, JA. Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology, and treatment. Compr Psychiatry
2000; 41: 405–15.
Olfson, M, Guardino, M, Struening, E, Schneier, FR, Hellman, F, Klein, DF. Barriers to the treatment of social anxiety. Am J Psychiatry
2000; 157: 521–7.
Heimberg, RG, Becker, RE. Cognitive-Behavioral Group Therapy for Social Phobia.
Guilford Press, 2002.
Blanco, C, Heimberg, RG, Schneier, FR, Fresco, DM, Chen, H, Turk, CL, et al. A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry
2010; 67: 286–95.
Blanco, C, Bragdon, LB, Schneier, FR, Liebowitz, MR. The evidence-based pharmacotherapy of social anxiety disorder. Int J Neuropsychopharmacol
2013; 16: 235–49.
Katzman, MA, Bleau, P, Blier, P, Chokka, P, Kjernisted, K, Van Ameringen, M. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry
2014; 14 (suppl 1): S1.
Rodebaugh, TL, Holaway, RM, Heimberg, RG. The treatment of social anxiety disorder. Clin Psychol Rev
2004; 24: 883–908.
Stangier, U, Heidenreich, T, Peitz, M, Lauterbach, W, Clark, DM. Cognitive therapy for social phobia: individual versus group treatment. Behav Res Ther
2003; 4: 991–1007.
Bouchard, S, Wiederhold, BK. Advances in Virtual Reality and Anxiety Disorders.
Bouchard, S, Bossé, J, Loranger, C, Klinger, É. Social anxiety disorder: efficacy and virtual humans. In Advances in Virtual Reality and Anxiety Disorders (eds Wiederhold, BK, Bouchard, S): 187–209. Springer, 2014.
Craske, MG, Treanor, M, Conway, CC, Zbozinek, T, Vervliet, B. Maximizing exposure therapy: An inhibitory learning approach. Behav Res Ther
2014; 58: 10–23.
Garcia-Palacios, A, Botella, C, Hoffman, H, Fabregat, S. Comparing acceptance and refusal rates of virtual reality exposure vs. in vivo exposure by patients with specific phobias. Cyberpsychol Behav
2007; 10: 722–4.
Owens, ME, Beidel, DC. Can virtual reality effectively elicit distress associated with social anxiety disorder?
J Psychopathol Behav Assess
2015; 37: 296–305.
North, MM, North, SM, Coble, JR. Virtual reality therapy: an effective treatment for the fear of public speaking. Int J Virtual Real
1998; 3: 2–6.
Harris, SR, Kemmerling, RL, North, MM. Brief virtual reality therapy for public speaking anxiety. Cyberpsychol Behav
2002; 5: 543–55.
Wallach, HS, Safir, MP, Bar-Zvi, M. Virtual reality cognitive behavior therapy for public speaking anxiety. Behav Modif
2009; 33: 314–39.
Anderson, PG, Price, M, Edwards, SM, Obasaju, MA, Schmertz, SK, Zimand, E, et al. Virtual reality exposure therapy for social anxiety disorder: a randomized controlled trial. J Consult Clin Psychol
2013; 81: 751–60.
Ngai, I, Tully, EC, Anderson, PL. The course of the working alliance during virtual reality and exposure group therapy for social anxiety disorder. Behav Cogn Psychother
2015; 43: 167–81.
Klinger, E, Bouchard, S, Légeron, P, Roy, S, Lauer, F, Chemin, I, et al. Virtual reality therapy versus cognitive behavior therapy for social phobia: a preliminary controlled study. Cyberpsychol Behav.
2005; 8: 76–88.
Kampmann, IL, Emmelkamp, PMG, Hartanto, D, Brinkman, W-P, Zijlstra, BJH, Morina, N. Exposure to virtual social interactions in the treatment of social anxiety disorder: a randomized controlled trial. Behav Res Ther
2016; 77: 147–56.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (Research edn).
Biometrics Research Department, 2002.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edn) . APA, 2013
Heeren, A, Maurage, P, Rossignol, M, Vanhaelen, M, Peschard, V, Eeckhout, C, et al. Self-report version of the Liebowitz Social Anxiety Scale: psychometric properties of the French version. Can J Behav Sci
2012; 44: 99–107.
Mennin, DS, Fresco, DM, Heimberg, RG, Schneier, FR, Davies, SO, Liebowitz, MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord
2002; 16: 661–73.
Safren, SA, Turk, CL, Heimberg, RG. Factor structure of the Social Interaction Anxiety Scale and the Social Phobia Scale. Behav Res Ther
1998; 36: 443–53.
Watson, D, Friend, R. Measurement of social-evaluative anxiety. J Consult Clin Psychol
1969; 33: 448–57.
Beck, AT, Steer, RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol
1984; 40: 1365–7.
Fydrich, T, Chambless, DL, Perry, KJ, Buergener, F, Beazley, MB. Behavioral assessment of social performance: a rating system for social phobia. Behav Res Ther
1998; 36: 995–1010.
Robillard, G, Bouchard, S, Dumoulin, S, Guitard, T. The development of the SWEAT questionnaire: a scale measuring costs and efforts inherent to conducting exposure sessions. In The Annual Review of Cybertherapy and Telemedicine (ed Wiederhold, BK, Riva, G, Kim, SI): 105–10. IOS Press, 2011.
Borkovec, TD, Nau, SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry
1972; 3: 257–60.
Horvath, AO, Greenberg, LS. The development and validation of the working alliance inventory. J Counsel Psychology
1989; 36: 223–33.
Kennedy, RS, Lane, NE, Berbaum, KS, Lilienthal, MG. Simulator Sickness Questionnaire: an enhanced method for quantifying simulator sickness. Int J Aviat Psychol
1993; 3: 203–20.
Bouchard, S, Robillard, G, Renaud, P. Revising the factor structure of the Simulator Sickness Questionnaire. Ann Rev Cyberther Telemed
2007; 5: 117–22.
Bouchard, S, St-Jacques, J, Renaud, P, Wiederhold, BK. Side effects of immersions in virtual reality for anxious people. J Cyber Ther Rehabil
2009; 2: 127–37.
Bouchard, S, Robillard, G, Renaud, P, Bernier, F. Exploring new dimensions in the assessment of virtual reality induced side effects. J Computer Inform Techn
2001; 1: 20–32.
Witmer, BG, Singer, MJ. Measuring presence in virtual environments: a presence questionnaire. Presence
1998; 7: 225–40.
Laforest, M, Bouchard, S, Crétu, AM, Mesly, O. Inducing an anxiety response using a “contaminated” virtual environment: validation of a therapeutic tool for obsessive-compulsive disorder. Front ITC
Clark, DM, Wells, A. A cognitive model of social phobia. In Social Phobia: Diagnosis, Assessment and Treatment (eds Heimberg, RG, Liebowitz, MR, Hope, DA, Schneier, FR): 69–93. Guilford Press, 1995.
Clark, DM, Ehlers, A, McManus, F, Hackmann, A, Fennell, M, Campbell, H, et al. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol
2003; 71: 1058–67.
Roy, S, Klinger, E, Légeron, P, Lauer, F, Chemin, I, Nugues, P. Definition of a VR-based protocol to treat social phobia. Cyberpsychol Behav
2003; 6: 411–20.
Bouchard, S, Gauthier, J, Laberge, B, French, D, Pelletier, MH, Godbout, C. Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia. Behav Res Ther
1996; 34: 213–24.
Emmelkamp, PMG, Krijn, M, Hulsbosch, AM, De Vries, S, Schuemie, MJ, Van der Mast, CAPG. Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia. Behav Res Ther
2002; 4: 509–16.
Bertrand, M, Bouchard, S. Applying the technology acceptance model to VR to people who are favorable to its use. J Cyber TherRehabil
2008; 1: 200–10.